Lever Bio

Lever Bio is a strategic initiative backed by Claris Ventures and Exor Ventures, focusing on advancing drug development through collaboration with top-tier researchers. The company operates at the intersection of science and business, aiming to translate groundbreaking discoveries into impactful therapeutics. Lever Bio prioritizes projects with validated targets in high medical need areas, particularly those originating from Italian research centers or Italian researchers abroad. By providing an initial budget to support partnered programs, Lever Bio seeks to progress these initiatives towards preclinical candidates. The business model revolves around forming strategic partnerships and leveraging a global business development network to drive innovation in drug development. Lever Bio's commitment to resource optimization and synergy creation positions it as a premier partner for researchers exploring new therapeutic opportunities.

Keywords: drug development, global partnerships, therapeutics, Claris Ventures, Exor Ventures, research collaboration, preclinical candidates, medical need, Italian research, resource optimization.